|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/22 | (2013.01) | ||
| C07K 16/22 | (2006.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61P 25/04 | (2018.01) | ||
| A61P 25/30 | (2018.01) | ||
| A61P 25/36 | (2018.01) |
| (11) | Number of the document | 3548082 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17817965.1 |
| Date of filing the European patent application | 2017-11-28 | |
| (97) | Date of publication of the European application | 2019-10-09 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/063417 |
| Date | 2017-11-28 |
| (87) | Number | WO 2018/102294 |
| Date | 2018-06-07 |
| (30) | Number | Date | Country code |
| 201662427365 P | 2016-11-29 | US |
| (72) |
STEHMAN-BREEN, Catherine , US
DAVIS, John , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | A PHARMACEUTICAL COMPOSITION FOR AVERTING OPIOID ADDICTION |
| A PHARMACEUTICAL COMPOSITION FOR AVERTING OPIOID ADDICTION |